L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]

L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]

Bai E, Yang L, Xiang Y, et al. Cancer Manag Res. 2018;10:565–581. During the publication process there was an operator error that resulted in the Western blot images of Figures 5A and 5B on page 575 appearing spliced. Read the original article

Bibliographic Details
Main Authors: Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Cancer Management and Research
Online Access:https://www.dovepress.com/httpswwwdovepresscomerratum-l61h46-shows-potent-efficacy-against-human-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/httpswwwdovepresscomerratum-l61h46-shows-potent-efficacy-against-human-peer-reviewed-article-CMAR

Similar Items